Xylem (XYL) Liabilities and Shareholders Equity (2016 - 2025)
Xylem has reported Liabilities and Shareholders Equity over the past 16 years, most recently at $17.6 billion for Q4 2025.
- Quarterly results put Liabilities and Shareholders Equity at $17.6 billion for Q4 2025, up 6.92% from a year ago — trailing twelve months through Dec 2025 was $68.7 billion (up 6.93% YoY), and the annual figure for FY2025 was $17.6 billion, up 6.92%.
- Liabilities and Shareholders Equity for Q4 2025 was $17.6 billion at Xylem, up from $17.3 billion in the prior quarter.
- Over the last five years, Liabilities and Shareholders Equity for XYL hit a ceiling of $17.6 billion in Q4 2025 and a floor of $7.9 billion in Q1 2023.
- Median Liabilities and Shareholders Equity over the past 5 years was $15.8 billion (2023), compared with a mean of $12.8 billion.
- Biggest five-year swings in Liabilities and Shareholders Equity: decreased 6.78% in 2022 and later soared 102.62% in 2023.
- Xylem's Liabilities and Shareholders Equity stood at $8.3 billion in 2021, then decreased by 3.91% to $8.0 billion in 2022, then skyrocketed by 102.62% to $16.1 billion in 2023, then increased by 2.36% to $16.5 billion in 2024, then rose by 6.92% to $17.6 billion in 2025.
- The last three reported values for Liabilities and Shareholders Equity were $17.6 billion (Q4 2025), $17.3 billion (Q3 2025), and $17.2 billion (Q2 2025) per Business Quant data.